VIR
Business Services · California, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
1800 Owens St Ste 900, San Francisco, Ca...Phone Number
(415) 906-4324Website
vir.bioRevenue
$64.7 MillionStock Symbol
VIRIndustry
ZI Rank: 2
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
4
4
1
1
2
About VIR
Vir Biotechnology is a biotechnology company focused on developing innovative therapies that harness the immune system to treat and prevent serious diseases. Its research centers on antibody-based medicines and immune technologies for infectious diseases, cancer, and immunology, with a pipeline targeting conditions such as hepatitis delta, hepatitis B, HIV, and other high unmet medical needs.Explore more
VIR Org Chart
EK
Vice President & Chief of Staff & Chief Marke...
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is VIR your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if VIR is spiking on competitors!
Click to see if VIR had a recent Job posting/layoffs
Check if VIR has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at VIR
Earning: See what the market has to say on VIR recently announced quarterly report
VIR, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once VIR has new funding data
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when VIR launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to VIR
Compare insights from companies similar to VIR, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
VIR
$64.7M
201-500
Public
$260M
2016
DB
Deborah BartonSenior Chief Marketing Officer, EA Office of & Corporate Communications Business Partner
Company Profile Activity
Activity Insights
VIR is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
VIR is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about VIR.
VIR financials insights
Gather financial insights about VIR, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Unspecified
$250M
2023
Grant
$10M
VIR Tech Stack
A closer look at the technologies used by VIR
Most Recent Scoops
Open Position
Open Position
Open Position
Project
Laboratory Operations, Medical Research, Clinical Operations
Open Position
VIR News & Media
Is Vir Biotechnology, Inc. (VIR) A Good Stock To Buy Now?
Is VIR a good stock to buy? We came across a bullish thesis on Vir Biotechnology, Inc. on Valueinvestorsclub.com by Bohr. In this article, we will summarize the bulls’ thesis on VIR. Vir Biotechnology, Inc.’s share was trading at $9.19 as of May 25th. VIR’s trailing P/E was 5.92 according to Yahoo Finance. Vir Biotechnology, Inc., a […]Why a Biotech Fund Opened a New $6 Million Position in Vir Amid a 99% Stock Rally
Vir Biotechnology develops immunology-based therapies targeting infectious diseases through global partnerships and scientific innovation.Vir Biotechnology Stock Has Nearly Doubled in a Year. One Major Holder Just Trimmed $17 Million
Vir Biotechnology develops immunology-based therapies for infectious diseases, backed by collaborations and a diversified research pipeline.Vir Biotechnology Stock Has Doubled This Past Year. One Fund Just Bought 1.2 Million Shares
Vir Biotechnology develops antibody and RNA-based therapies for infectious diseases, leveraging partnerships and a robust clinical pipeline.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding VIR
Sign Up For FreeTo access detailed company insights
Vir Biotechnology is a biotechnology company focused on developing innovative therapies that harness the immune system to treat and prevent serious diseases. Its research centers on antibody-based medicines and immune technologies for infectious diseases, cancer, and immunology, with a pipeline targeting conditions such as hepatitis delta, hepatiti... Read More
